Clark David J 4
4 · Trevi Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-15+175,000→ 175,000 totalExercise: $2.38Exp: 2034-02-14→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 15, 2024. The 175,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028.